Completed
Study of Biomarker Profiles in Asia Pacific erb2+/HER2 Breast Cancer Patients Treated With Lapatinib
NCT01248897
- Conditions
- Neoplasm Metastasis, Neoplasms, Neoplasms, Metastasis, +3 more
- Locations
-
- GSK Investigational Site Hong Kong
- GSK Investigational Site Pokfulam, Hong Kong
- GSK Investigational Site Tuenmen, Hong Kong
- GSK Investigational Site Wan Chai, Hong Kong